The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sosnova E.A.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

Kerimli L.M.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

THE CHANGES OF PROLACTIN MOLECULAR POLYMORPHISM AS A PREDICTOR OF PREGNANCY LOSS

Authors:

Sosnova E.A., Kerimli L.M.

More about the authors

Read: 667 times


To cite this article:

Sosnova EA, Kerimli LM. THE CHANGES OF PROLACTIN MOLECULAR POLYMORPHISM AS A PREDICTOR OF PREGNANCY LOSS. Russian Journal of Human Reproduction. 2012;(4):84‑88. (In Russ.)

Recommended articles:
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30

References:

  1. Bulatov A.A. Fenomen makroprolaktinemii, ego proiskhozhdenie i kliniko-diagnosticheskoe znachenie. Probl endokrinol 1997; 43: 3: 50-55.
  2. Ilovaiskaya I.A., Marova E.I. Biologiya prolaktina. Molekulyarnye formuly prolaktina. Akush i ginekol 2000; 6: 3-6.
  3. Kvetnoi I.M., Ailamazyan E.K., Lapina E.A., Kolobov A.V. Signal'nye molekuly-markery zrelosti platsenty. M: MEDpress-inform 2005.
  4. Bigazzi M., Nardi E. Prolactin and relaxin: antagonism on the spontaneous motility of the uterus. Clin Endocrin Metabol 2007; 53: 3: 665-667.
  5. Demers L., Hughes E. et al. Organ culture of human endometrium. Effects of progesterone. Obstet Gynecol Surv 2006; 34: 2: 252-259.
  6. Diver M., Ewins D. et al. An unusual form of macroprolactin in a pregnant patient. Endocrinol 2004; 5: 1: 41-45.
  7. Hattori N., Nakayama Y., Kitagawa K. et al. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia. Clin Endocrinol 2008; 68: 1: 72-76.
  8. Hauache O., Oliveira J., Tachibana T. et al. Evaluation of plasma prolactin levels. Endocrin Metabol 2006; 50: 3: 569-570.
  9. Herbert F., Sparkle D., Moore G. et al. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Endocrinol 2009; 9: 3: 602-606.
  10. Leslie H., Courtney C., Bell P. et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Clin Endocrin Metabol 2001; 86: 6: 2743-2746.
  11. Pascoe-Lira D., Duran-Reyes G., Contreras-Hernandez I. et al. Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. Clin Endocrin Metabol 2001; 86: 2: 924-929.
  12. Schindler A. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Maturitas 2009; 65: 3-11.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.